Skip to main content

Table 1 The main demographic and clinical characteristics of the four study groups

From: Epigenetic features of FoxP3 in children with cow’s milk allergy

 

Subjects with CMA at diagnosis

Subjects outgrown CMA

Healthy subjects

EHCF + LGG

Other formulas

Group 1

Group 2

Group 3

Group 4

Number

10

10

10

10

Male, number (%)

7 (70)

7 (70)

6 (60)

4 (40)

Age, months (SD)

5.5 (0.7)

16.9 (0.9)

17 (0.9)

9 (4)

Body weight, kg (SD)

7.385 (964.7)

12.047 (682.4)

12.273 (776.7)

8.075 (3193.5)

Spontaneous delivery, number (%)

5 (50)

2 (20)

3 (30)

4 (40)

Breastfeeding, ≤8 weeks, number (%)

10 (100)

10 (100)

10 (100)

10 (100)

Symptoms at the CMA onset

   

 Gastrointestinal, n (%)

4 (40)

5 (50)

3 (30)

 Cutaneous, n (%)

8 (80)

8 (80)

7 (70)

 Respiratory, n (%)

1 (10)

3 (30)

3 (30)

Total serum IgE, kU/l (SD)

260.6 (230.9)

255.9 (236.1)

130.4 (167.9)

0.2 (0.1)

Alpha-lactalbumin, kUA/l(SD)

6 (11.2)

0.6 (0.7)

3.1 (3.9)

Beta-lactoglobulin, kUA/l(SD)

4.5 (7.1)

2.2 (3.4)

1.9 (2.6)

Bovine serum albumin, kUA/l(SD)

5.4 (8.7)

0.9 (1.8)

1.9 (3)

nBCasein, kUA/l(SD)

22.7 (39.2)

0.5 (0.4)

1.3 (2.7)

Lactoferrin, kUA/l(SD)

2 (6.1)

0

0